A Novel Natural Product-Derived Compound, Vestaine A 1 , Exerts both Pro-Angiogenic and Anti-Permeability Activity via a Different Pathway from VEGF

[...]a treatment to eliminate the fragile vessels by suppressing excess angiogenesis or enhancing vessel maturation would be useful for treating these clinical conditions. Recently, anti-VEGF antibodies have been approved to treat eye diseases such as age-related macular degeneration and cancer, and...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Cellular physiology and biochemistry 2016-11, Vol.39 (5), p.1905-1918
Hauptverfasser: Ishimoto, Yoko, Hirota-Takahata, Yuki, Kurosawa, Emi, Chiba, Jun, Iwadate, Yuko, Onozawa, Yoshiko, Hasegawa, Toru, Tamura, Akihiro, Tanaka, Masahiro, Kobayashi, Hideki
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:[...]a treatment to eliminate the fragile vessels by suppressing excess angiogenesis or enhancing vessel maturation would be useful for treating these clinical conditions. Recently, anti-VEGF antibodies have been approved to treat eye diseases such as age-related macular degeneration and cancer, and show steady efficacy [1, 10, 11]. [...]medicines which accomplish abnormal vessel elimination through mechanisms different from anti-VEGF therapy would be useful to provide other options for patients showing resistance or insufficient response to the anti-VEGF therapy. Power SYBR Green PCR Master Mix and Taqman Gene Expression Master Mix were purchased from Applied Biosystems. After being stirred for 15 min at that temperature, N-acetyl-L-cysteine (1.6 g, 9.67 mmol) was added to the reaction mixture and stirred for 1 h. The reaction mixture was warmed up to room temperature and stirred for 1 h. The reaction was quenched by addition of 1 N HCl (30 ml) at 0°C and extracted with ethyl acetate.
ISSN:1015-8987
1421-9778
DOI:10.1159/000447888